StreetAlpha.app
Home › Stocks › ZTS

Zoetis Inc. (ZTS)

Healthcare
$79.11
▼ −2.08%
LAST CLOSE · NOV 20

Zoetis makes medicines, vaccines, diagnostic tests and other products that help veterinarians, farmers and pet owners care for animals. It last closed at $79.11 on Nov 20, down 2.08% on the day. The next earnings report for ZTS is expected around Thu, Feb 11, 2027. For the quarter ended Sep 2026, ZTS reported EPS of $1.44 on revenue of $2.39B, with revenue down 1.3% from a year ago. Over its last 8 reports the stock moved an average of 7.9% the session after earnings. Over the last 12 months ZTS insiders bought $886K of stock on the open market and sold $2.5M, according to SEC Form 4 filings.

AI Auto Pilots
Is ZTS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ZTS.

Key Stats

Last 12 months
Results
Revenue
$9.5B
+0.9% vs a year ago
Net income
$2.5B
−4.7% vs a year ago
EPS (diluted)
$5.93
+0.7% vs a year ago
Free cash flow
$2.2B
23.5% margin
Valuation
Market cap
$32.1B
406.3M shares
P/E
13.3
Price over 12 month EPS
Price to sales
3.4
Market cap over revenue
Dividend yield
2.64%
$2.09 a share over 12 months
Balance sheet
Cash & equivalents
$1.3B
At Sep 30
Debt
$9.0B
At Sep 30
Shareholder equity
$3.3B
Buybacks
$3.8B
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $7.8B$7.8BFY2021FY2022: $8.1B$8.1BFY2022FY2023: $8.5B$8.5BFY2023FY2024: $9.3B$9.3BFY2024FY2025: $9.5B$9.5BFY2025

From ZTS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 11
Estimated date · Time not announced
Reported EPS
$1.44
Quarter ended Sep 2026
Year ago EPS
$1.63
−11.7% on a GAAP basis
Revenue
$2.39B
−1.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.29Dec '24Mar 2025: $1.34Mar '25Jun 2025: $1.63Jun '25Sep 2025: $1.63Sep '25Dec 2025: $1.42Dec '25Mar 2026: $1.42Mar '26Jun 2026: $1.65Jun '26Sep 2026: $1.44Sep '26Latest $1.44
Revenue by quarter
Dec 2024: $2.32BDec '24Mar 2025: $2.20BMar '25Jun 2025: $2.47BJun '25Sep 2025: $2.42BSep '25Dec 2025: $2.37BDec '25Mar 2026: $2.26BMar '26Jun 2026: $2.47BJun '26Sep 2026: $2.39BSep '26Latest $2.39B
How ZTS moved after its last 8 reports
Average move the session after a report ±7.9%
Nov 5, 2026Time not announced−8.0%
Aug 6, 2026Time not announced+3.9%
May 7, 2026Time not announced−21.5%
Feb 12, 2026Time not announced−2.4%
Nov 4, 2025Time not announced−13.8%
Aug 5, 2025Time not announced−3.8%
May 6, 2025Time not announced−5.2%
Feb 13, 2025Time not announced−5.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ZTSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ZTS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ZTS

Technical Analysis

ZTS · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 14% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 46). The nearest support is the swing low (Nov 6) at $78.63, and the nearest resistance the swing high (Jul 28) at $79.43.

Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 3.6%/day
Key levels
$132.4952 week high+67.5%
$90.42200 day average+14.3%
$81.9920 day average+3.6%
$81.86Pivot R1+3.5%
$80.33Pivot+1.5%
$79.43Swing high (Jul 28)+0.4%
$79.11Last close
$78.63Swing low (Nov 6)−0.6%
$77.58Pivot S1−1.9%
$77.1950 day average−2.4%
$76.37100 day average−3.5%
$68.7752 week low−13.1%
Indicators
RSI (14)46.23Middle of its rangeNeutral
MACD1.25Below its signal lineBearish
Stochastic30.0Middle of its rangeNeutral
ADX (14)31.5Trending up
Williams %R-95.5Oversold below −80, overbought above −20Oversold
CCI (20)-59.6Oversold below −100, overbought above 100Neutral
Rate of change−0.4%Change over 10 sessionsBearish
ATR (14)$2.87Typical daily range, 3.6% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Below
What happened before, for ZTS

What happened before

See how ZTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ZTS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ZTS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ZTSHow many large options trades hit ZTS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

ZTS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼613 buying vs 755 selling
  • ▼Held by funds -4.8 pts
  • ▼Funds holding -80
  • ●Superinvestors: 3 added, 3 cut
  • ▼Put/call 0.53 to 1.11
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,3591,439−5.6%
In funds' top 1089−11.1%
Held by funds93.1%97.9%−4.8 pts
New / increased127 / 486156 / 511−8.1%
Reduced / sold out559 / 196597 / 339−19.3%
Put/call ratio1.110.53+108.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ZTS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ZTS Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$886K3 buys · 3 insiders
Sold$2.5M1 sale · 1 insider
100% of the selling was under pre-arranged trading plans.
Cluster buy: 3 insiders bought $886K between May 11 and May 13.
2026-02 sold $2.5M2026-05 bought $886KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
May 13Paul BisaroDirectorBuy2,000$75.88$152K
May 13Frank A DamelioDirectorBuy6,650$75.39$501K
May 11Michael B MccallisterDirectorBuy3,000$77.76$233K
Feb 17Kristin C PeckCEOSale plan20,000$127.05$2.5M
Jun 3, 2025Roxanne LaganoExecutive Vice PresidentSale plan652$170.00$111K
Mar 11, 2025Willie M ReedDirectorSale1,210$166.14$201K
Every insider buy and sale for ZTS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ZTS insider trades →

From SEC Form 4 filings by ZTS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

ZTS Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$3.8B
11.7% yield
Left in program
$770.1M
2.4% of value
Shares outstanding, 12 months
−7.8%
Fewer shares
Last quarter
$499.8M
Sep 2026
Avg price paid, last quarter
$74.77
6.7M shares bought
S&P 500 rank by spending
#65 of 358
 
Spent each quarter, last 3 yearsTop bar $2.1B
Dec 2023: $235.8M, average price $174.19Mar 2024: $363.5M, average price $186.45Jun 2024: $532.5M, average price $167.00Sep 2024: $425.8M, average price $183.49Dec 2024: $552.5M, average price $177.26Mar 2025: $462.0M, average price $165.05Jun 2025: $337.2M, average price $157.48Sep 2025: $377.2M, average price $151.42Dec 2025: $2.1B, average price $124.31Mar 2026: $619.2M, average price $125.07Jun 2026: $550.2M, average price $88.59Sep 2026: $499.8M, average price $74.77
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ZTS is in one of them and how their past ZTS trades turned out.

ZTS in the AI portfolios
Loading…

ZTS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ZTS in an article yet. Here's the latest on the wider market.

ZTS in the news

ZTS Congress Trades

All congress trades →
Trades, 12 months
20
Buys
10
50%
Sells
10
50%
People
5
Last filed Nov 16
Who traded ZTS · since 2015
Latest 5 filings of 112
$1K – $15KTraded Oct 2, 2026Filed Nov 16, 2026
$1K – $15KTraded Oct 2, 2026Filed Nov 16, 2026
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 21, 2026Filed Nov 4, 2026
PersonTypeAmountTradedFiledDelay
Byron DonaldsR · FLSell$1K – $15KOct 2, 2026Nov 16, 202645 d
Byron DonaldsR · FLSell$1K – $15KOct 2, 2026Nov 16, 202645 d
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Shelley CapitoR · WVSell$1K – $15KOct 21, 2026Nov 4, 202614 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Zoetis

Zoetis is an animal health company based in Parsippany, New Jersey. It develops and sells medicines, vaccines, diagnostic tests, genetic products and digital tools for pets and farm animals. Its customers include veterinarians, livestock producers and pet owners, and its products are sold in many countries. The company serves both companion animals and livestock across a range of species.

Headquarters
Parsippany, NJ
Founded
1952